https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/accounts-notes-and-loans-receivable-net-current https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/accounts-payable https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/advances-on-inventory-purchases https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/allowance-for-doubtful-other-receivables-current https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/amended-reports-10-k https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/amended-reports-10-q https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/aoci https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/capital-expenditures https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/cash-and-equivalents https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/cash-flow-breakdown https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/common-stock-value https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/comprehensive-income https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/comprehensive-income-net-of-tax-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/cost-of-goods-sold https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/current-assets https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/current-liabilities https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/customer-advances-current https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/deferred-tax-assets-net-current https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/deposit-liability-current https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/depreciation-and-amortization https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/due-from-related-parties-current https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/due-to-related-parties-current https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/financing-cash-flow https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/general-and-administrative-expense https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/gross-profit https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/income-tax https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/income-taxes-paid https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/increase-decrease-in-accounts-and-notes-receivable https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/increase-decrease-in-customer-advances https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/increase-decrease-in-deposits https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/increase-decrease-in-due-from-related-parties https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/increase-decrease-in-other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/insider-transactions-other https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/insider-transactions-warrants https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/interest-expense https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/interest-paid https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/inventory https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/investing-cash-flow https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/investment-income-interest https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/long-term-debt https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/minority-interest https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/minority-interest-change https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/net-change-in-cash https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/net-income https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/noncontrolling-interest-decrease-from-deconsolidation https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/operating-cash-flow https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/operating-expenses https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/operating-income https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/other-current-assets https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/other-income https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/other-noncurrent-assets https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/other-nonoperating-expense https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/other-nonoperating-income https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/other-receivables-net-current https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/other-significant-noncash-transaction-value-of-consideration-received https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/paid-in-capital-other https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/proceeds-from-minority-shareholders https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/proceeds-from-repayments-of-restricted-cash-financing-activities https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/profit-loss https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/property-plant-equipment https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/public-float https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/repayments-of-debt https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/research-and-development https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/retained-earnings-appropriated https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/retained-earnings-unappropriated https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/revenue https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/sec-filings-10-k https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/sec-filings-10-q https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/sec-filings-10ksb https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/sec-filings-10qsb https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/sec-filings-10sb12g https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/sec-filings-15f-12g https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/sec-filings-25 https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/sec-filings-8-k https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/sec-filings-certamx https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/sec-filings-def-14a https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/sec-filings-defr14a https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/sec-filings-no-act https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/sec-filings-sb-2 https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/sec-filings-sc-14f1 https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/selling-expense https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/shareholders-equity https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/shares-authorized https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/shares-issued https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/short-term-borrowings https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/total-assets https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/total-liabilities https://stock.noler.com/us/stock/china-shenghuo-pharmaceutical-holdings-inc/total-liabilities-and-equity